| Literature DB >> 28362066 |
Aaron F Bochner1,2, Caryl Feldacker1,3, Batsi Makunike4, Marrianne Holec1, Vernon Murenje4, Abby Stepaniak1, Sinokuthemba Xaba5, Shirish Balachandra6, Mufuta Tshimanga7, Vts Chitimbire8, Scott Barnhart1,3,9.
Abstract
INTRODUCTION: The frequency of adverse events (AEs) is a widely used indicator of voluntary medical male circumcision (VMMC) programme quality. Though over 11.7 million male circumcisions (MCs) have been performed, little published data exists on the profile of AEs from mature, large-scale programmes. No published data exists on routine implementation of PrePex, a device-based MC method.Entities:
Keywords: HIV prevention; Male circumcision; PrePex; Zimbabwe; adverse events
Mesh:
Year: 2017 PMID: 28362066 PMCID: PMC5467584 DOI: 10.7448/IAS.20.1.21394
Source DB: PubMed Journal: J Int AIDS Soc ISSN: 1758-2652 Impact factor: 5.396
Characteristics of VMMC clients from October 2014 to September 2015
| Characteristics | VMMC Clients |
|---|---|
| Age | |
| 10–14 | 19,619 (43.7%) |
| 15–19 | 15,129 (33.7%) |
| 20–24 | 4,816 (10.7%) |
| 25–29 | 2,508 (5.6%) |
| 30–49 | 2,541 (5.7%) |
| >50 | 255 (0.6%) |
| MC method | |
| Surgical (forceps-guided or dorsal slit) | 41,416 (92.3%) |
| PrePex | 3,452 (7.7%) |
| HIV-1 serostatus | |
| Negative | 44,484 (99.2%) |
| Positive | 230 (0.5%) |
| Unknown | 154 (0.3%) |
| Location type where MC was performed | |
| Static facility | 10,459 (23.3%) |
| Outreach or caravan | 34,409 (76.7%) |
| Follow-up visit within 14 days of MC | |
| Yes | 43,180 (96.2%) |
| No | 1,688 (3.8%) |
Moderate and severe adverse events listed by male circumcision method
| Intraoperative | Postoperative | |||||
|---|---|---|---|---|---|---|
| AE type | Moderate | Severe | Moderate | Severe | Totals | Rate per 10,000 MCs |
| Surgical | ||||||
| Bleeding | 2 | 1 | 13 | 4 | 20 | 4.8 |
| Infection | 0 | 0 | 57 | 10 | 67 | 16.2 |
| Insufficient skin removal | 0 | 0 | 0 | 3 | 3 | 0.7 |
| Other | 0 | 0 | 0 | 1 | 1 | 0.2 |
| Pain | 0 | 1 | 0 | 0 | 1 | 0.2 |
| Scarring, disfigurement, or damage to penis | 0 | 2 | 0 | 1 | 3 | 0.7 |
| Swelling | 0 | 0 | 2 | 3 | 5 | 1.2 |
| Wound disruption | 0 | 0 | 14 | 2 | 16 | 3.9 |
| Subtotal | 2 | 4 | 86 | 24 | 116 | 28.0 |
| PrePex | ||||||
| Device displacement | - | - | 2 | 26 | 28 | 81.1 |
| Infection | - | - | 7 | 0 | 7 | 20.3 |
| Pain | - | - | 3 | 1 | 4 | 11.6 |
| Swelling | - | - | 1 | 0 | 1 | 2.9 |
| Subtotal | - | - | 13 | 27 | 40 | 115.9 |
| Total AEs | 2 | 4 | 99 | 51 | 156 | 34.8 |
Factors associated with experiencing a moderate or severe adverse event
| N with AE/Total (%) | Unadjusted RR (95% CI) | Adjusted RR (95% CI)1 | |
|---|---|---|---|
| Age | |||
| ≥20 | 43/10,120 (0.42%) | 1.00 (ref) | 1.00 (ref) |
| 15–19 | 49/15,129 (0.32%) | 0.76 (0.51–1.15) | 0.87 (0.56–1.36) |
| 10–14 | 64/19,619 (0.33%) | 0.77 (0.52–1.13) | 0.83 (0.49–1.39) |
| MC method | |||
| Surgical (forceps-guided or dorsal slit) | 116/41,416 (0.28%) | 1.00 (ref) | 1.00 (ref) |
| PrePex | 40/3,452 (1.16%) | 4.14 (2.89–5.92) | 3.29 (1.78–6.06)2 |
| Location type where MC was performed3 | |||
| Outreach or caravan | 98/34,409 (0.29%) | 1.00 (ref) | 1.00 (ref) |
| Static facility | 48/10,459 (0.46%) | 1.61 (1.14–2.27) | 1.14 (0.56–2.30) |
1 Adjusted for site and allowing for clustering. Eight sites were excluded from the adjusted analysis due to having no adverse events. An additional nine sites were excluded from the adjusted MC method analysis because those sites only conducted surgical procedures. N = 36,534 MC clients included in the age and location adjusted analysis, N = 23,777 MC clients included in the MC method analysis.
2 P < 0.0005
3 For 10 AEs, the location where the MC was performed was not recorded.
Factors associated with experiencing moderate or severe infection
| N with Inf./Total (%) | Unadjusted RR (95% CI) | Adjusted RR (95% CI)1 | |
|---|---|---|---|
| Age | |||
| ≥20 | 6/10,120 (0.06%) | 1.00 (ref) | 1.00 (ref) |
| 15–19 | 21/15,129 (0.14%) | 2.34 (0.95–5.80) | 1.80 (0.82–3.92) |
| 10–14 | 47/19,619 (0.24%) | 4.04 (1.73–9.45) | 3.07 (1.36–6.91)2 |
| MC method | |||
| Surgical (forceps-guided or dorsal slit) | 67/41,416 (0.16%) | 1.00 (ref) | 1.00 (ref) |
| PrePex | 7/3,452 (0.20%) | 1.25 (0.58–2.73) | 1.43 (0.52–3.93) |
| Location type where MC was performed3 | |||
| Outreach or caravan | 56/34,409 (0.16%) | 1.00 (ref) | 1.00 (ref) |
| Static facility | 16/10,459 (0.15%) | 0.94 (0.54–1.64) | 1.21 (0.41–3.58) |
1 Analyses adjusted for site and allowing for clustering. 18 sites were excluded from the adjusted analysis due to having no infection adverse events. N = 24,370 MC clients included in the analysis.
2 P < 0.01
3 For two infection AEs, the location where the MC was performed was not recorded.